ATE457308T1 - Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta - Google Patents
Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-betaInfo
- Publication number
- ATE457308T1 ATE457308T1 AT04759766T AT04759766T ATE457308T1 AT E457308 T1 ATE457308 T1 AT E457308T1 AT 04759766 T AT04759766 T AT 04759766T AT 04759766 T AT04759766 T AT 04759766T AT E457308 T1 ATE457308 T1 AT E457308T1
- Authority
- AT
- Austria
- Prior art keywords
- estrogen receptor
- receptor beta
- selective antagonists
- substituted benzopyrans
- substituted
- Prior art date
Links
- 150000001562 benzopyrans Chemical class 0.000 title abstract 2
- 102000000509 Estrogen Receptor beta Human genes 0.000 title 1
- 108010041356 Estrogen Receptor beta Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000000556 agonist Substances 0.000 abstract 2
- 102000015694 estrogen receptors Human genes 0.000 abstract 2
- 108010038795 estrogen receptors Proteins 0.000 abstract 2
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46440503P | 2003-04-21 | 2003-04-21 | |
| PCT/US2004/009271 WO2004094401A1 (en) | 2003-04-21 | 2004-04-08 | Substituted benzopyrans as selective estrogen receptor-beta agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE457308T1 true ATE457308T1 (de) | 2010-02-15 |
Family
ID=33310883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04759766T ATE457308T1 (de) | 2003-04-21 | 2004-04-08 | Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7279499B2 (de) |
| EP (1) | EP1618102B1 (de) |
| AT (1) | ATE457308T1 (de) |
| DE (1) | DE602004025460D1 (de) |
| ES (1) | ES2338119T3 (de) |
| WO (1) | WO2004094401A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE406373T1 (de) | 2003-04-21 | 2008-09-15 | Lilly Co Eli | Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta |
| CN101052641A (zh) | 2004-09-07 | 2007-10-10 | 惠氏公司 | 6H－[1]苯并吡喃并[4,3－b]喹啉及其作为雌激素药物的用途 |
| CA2578300A1 (en) * | 2004-10-18 | 2006-04-27 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
| GT200500317A (es) | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
| WO2006088716A1 (en) | 2005-02-15 | 2006-08-24 | Eli Lilly And Company | Substituted tetralins as selective estrogen receptor-beta agonists |
| AR054849A1 (es) | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
| AR056695A1 (es) * | 2005-10-17 | 2007-10-17 | Wyeth Corp | Tetrahidroquinolinas, su sintesis e intermediarios |
| EA026578B1 (ru) | 2007-01-22 | 2017-04-28 | ДЖиТиЭкс, ИНК. | Вещества, связывающие ядерные рецепторы |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| EP2278999B1 (de) | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Ohrbehandlungsformulierungen zur behandlung von ohrenerkrankungen und -leiden |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| US8784870B2 (en) * | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
| EP2306975A4 (de) | 2008-07-21 | 2012-10-31 | Otonomy Inc | Zusammensetzungen mit gesteuerter freisetzung zur modulierung der ohrenstruktur und des angeborenen immunsystems sowie verfahren zur behandlung von ohrerkrankungen |
| WO2011014516A1 (en) | 2009-07-28 | 2011-02-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Estrogen antagonists as treatments for sclerosing disorders |
| WO2011035209A1 (en) * | 2009-09-17 | 2011-03-24 | Vanderbilt Universtiy | Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| AU2014353150A1 (en) | 2013-11-19 | 2016-07-07 | Vanderbilt University | Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mGluR5 |
| AU2014353006B2 (en) | 2013-11-20 | 2019-04-04 | Signalchem Life Sciences Corp. | Quinazoline derivatives as TAM family kinase inhibitors |
| US9974776B2 (en) | 2013-12-05 | 2018-05-22 | Karo Pharma Ab | Estrogen receptor beta agonists for use in treating mesothelioma |
| US9533982B2 (en) | 2014-03-20 | 2017-01-03 | Vanderbilt University | Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators |
| US9550778B2 (en) | 2014-10-03 | 2017-01-24 | Vanderbilt University | Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5 |
| AU2017290256A1 (en) | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100263137B1 (ko) | 1995-09-08 | 2000-08-01 | 오테스코그 페르 | 오판 수용체 |
| AU8102398A (en) | 1997-07-09 | 1999-02-08 | Central Drug Research Institute | (dl)-2,3-diaryl-2h-1-benzopyrans |
| IL150463A0 (en) | 1999-12-30 | 2002-12-01 | Signal Pharm Inc | Compounds and methods for modulation of estrogen receptors |
| AU2001256164A1 (en) * | 2000-03-01 | 2001-09-12 | Akzo Nobel N.V. | Chroman derivatives as estrogenic compounds |
| JP2003528858A (ja) | 2000-03-27 | 2003-09-30 | アクゾ・ノベル・エヌ・ベー | エストロゲン関連治療用のノンステロイド系四環式化合物 |
| GB2361642A (en) | 2000-10-24 | 2001-10-31 | Karobio Ab | Estrogen receptor beta (ERbeta) agonists for use in cancer treatment |
| WO2003044006A1 (en) * | 2001-11-19 | 2003-05-30 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
| US6914074B2 (en) | 2001-12-13 | 2005-07-05 | Wyeth | Substituted phenyl naphthalenes as estrogenic agents |
| US6630508B1 (en) | 2002-02-11 | 2003-10-07 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor β agonists |
-
2004
- 2004-04-08 DE DE602004025460T patent/DE602004025460D1/de not_active Expired - Lifetime
- 2004-04-08 AT AT04759766T patent/ATE457308T1/de not_active IP Right Cessation
- 2004-04-08 US US10/549,106 patent/US7279499B2/en not_active Expired - Fee Related
- 2004-04-08 ES ES04759766T patent/ES2338119T3/es not_active Expired - Lifetime
- 2004-04-08 WO PCT/US2004/009271 patent/WO2004094401A1/en not_active Ceased
- 2004-04-08 EP EP04759766A patent/EP1618102B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20060199858A1 (en) | 2006-09-07 |
| DE602004025460D1 (de) | 2010-03-25 |
| EP1618102B1 (de) | 2010-02-10 |
| EP1618102A1 (de) | 2006-01-25 |
| ES2338119T3 (es) | 2010-05-04 |
| WO2004094401A1 (en) | 2004-11-04 |
| US7279499B2 (en) | 2007-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE457308T1 (de) | Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta | |
| IL185867A0 (en) | Substituted benzopyrans as selective estrogen receptor-beta agonists | |
| CY1110443T1 (el) | Υποκατεστημενα βενζοπυρανια ως εκλεκτικοι αγωνιστες υποδοχεα-βητα οιστρογονων | |
| MY141733A (en) | Benzimidazole and pyridylimidazole derivatives as ligands for gabaa receptors | |
| EA200501430A1 (ru) | Лиганды каннабиноидных рецепторов и их применение | |
| DE60107687D1 (de) | Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden | |
| BR0215360A (pt) | Derivados de indolina úteis como inibidores de proteìna quinase | |
| ATE466002T1 (de) | Substituierte benzo (d) isoaxol-3-yl-amin- verbindungen als analgetika | |
| ATE292118T1 (de) | Pyrazolderivative als p-38 map kinase inhibitoren | |
| PT925301E (pt) | Derivados altamente lipofilos de camptotecina | |
| ATE493418T1 (de) | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren | |
| DE60221425D1 (de) | Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase-inhibitoren | |
| PT1165544E (pt) | 1,4-di-hidroindeno¬1,2-c|pirazoles substituidos como inibidores de tirosina-quinase | |
| ATE296818T1 (de) | Substituierte 6h-dibenzo(c,h)chromene als oestrogene agentien | |
| MY117975A (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
| SE0001373D0 (sv) | NPY Y1 receptor agonists and antagonists | |
| MY129677A (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
| MY120281A (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
| ATE394386T1 (de) | 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren | |
| DE602004018844D1 (de) | Als antagonisten des muscarinrezeptors geeignete xanthinderivate | |
| HN2001000165A (es) | Derivados de imidazol | |
| CY1114525T1 (el) | (s)-n-methylnaltrexone,(μεθυλναλτρεξονη), διαδικασιες για την συνθεση της και η φαρμακευτικη της χρηση |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |